PL3974027T3 - Stabilizowany peptyd pacap - Google Patents

Stabilizowany peptyd pacap

Info

Publication number
PL3974027T3
PL3974027T3 PL20805414.8T PL20805414T PL3974027T3 PL 3974027 T3 PL3974027 T3 PL 3974027T3 PL 20805414 T PL20805414 T PL 20805414T PL 3974027 T3 PL3974027 T3 PL 3974027T3
Authority
PL
Poland
Prior art keywords
stabilized
pacap peptide
pacap
peptide
stabilized pacap
Prior art date
Application number
PL20805414.8T
Other languages
English (en)
Inventor
Shinnosuke MACHIDA
Takeshi Nakajima
Original Assignee
Senju Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co., Ltd. filed Critical Senju Pharmaceutical Co., Ltd.
Publication of PL3974027T3 publication Critical patent/PL3974027T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20805414.8T 2019-05-14 2020-05-14 Stabilizowany peptyd pacap PL3974027T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019091696 2019-05-14
PCT/JP2020/019344 WO2020230867A1 (ja) 2019-05-14 2020-05-14 Ｐａｃａｐの安定化ペプチド

Publications (1)

Publication Number Publication Date
PL3974027T3 true PL3974027T3 (pl) 2025-02-24

Family

ID=73290045

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20805414.8T PL3974027T3 (pl) 2019-05-14 2020-05-14 Stabilizowany peptyd pacap

Country Status (7)

Country Link
US (1) US20250263459A1 (pl)
EP (1) EP3974027B1 (pl)
JP (2) JPWO2020230867A1 (pl)
CN (1) CN113853236B (pl)
ES (1) ES2991433T3 (pl)
PL (1) PL3974027T3 (pl)
WO (1) WO2020230867A1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6680295B1 (en) * 1994-09-22 2004-01-20 The Administrators Of The Tulane Educational Fund Method and pharmaceutical composition for prevention and treatment of brain damage
JP2004168697A (ja) * 2002-11-19 2004-06-17 Senju Pharmaceut Co Ltd 網膜疾患治療剤
CN1913914A (zh) * 2004-01-27 2007-02-14 拜尔药品公司 垂体腺苷酸环化酶激活肽(pacap)受体(vpac2)激动剂及其药理学使用方法
US20110212899A1 (en) * 2004-04-23 2011-09-01 Yoshiko Takayama Corneal Neuritogenesis Promoter Containing Pacap and Its Derivative
JP2009269818A (ja) 2006-08-22 2009-11-19 Univ Showa Ｐａｃａｐペプチドを含む眼科用剤
BR112013024323A2 (pt) 2011-03-24 2017-06-13 Neurim Pharmaceuticals ( 1991 ) Ltd peptídeos neuroprotetores
ITMI20110583A1 (it) * 2011-04-08 2012-10-09 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di pacap (pituitary adenylate cyclase activating polypeptide) al fine di ripristinare la normale funzione visiva nel glaucoma in fase precoce
JP5775356B2 (ja) 2011-05-09 2015-09-09 松本　明 神経保護作用を有するペプチド及びこれを含む薬剤
EP3019184A4 (en) * 2013-06-07 2017-04-05 The Administrators of the Tulane Educational Fund Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use
WO2017027848A1 (en) 2015-08-12 2017-02-16 The Arizona Board Of Regents On Behalf Of The University Of Arizona Glycosylated peptides with pseudoproline residues and having enhanced half-lives and ability to cross the blood brain barrier

Also Published As

Publication number Publication date
WO2020230867A1 (ja) 2020-11-19
JPWO2020230867A1 (pl) 2020-11-19
CN113853236A (zh) 2021-12-28
ES2991433T3 (es) 2024-12-03
CN113853236B (zh) 2025-04-22
US20250263459A1 (en) 2025-08-21
EP3974027A1 (en) 2022-03-30
JP2024166370A (ja) 2024-11-28
EP3974027A4 (en) 2023-08-16
EP3974027B1 (en) 2024-10-23

Similar Documents

Publication Publication Date Title
UA42395S (uk) Футляр
EP3994692C0 (en) BINARY COMPUTING CELL IN MEMORY
EP3833739A4 (en) STRAIN OF AKKERMANSIA MUCINIPHILA
EP4079231A4 (en) Sheath
EP3919488A4 (en) IMMUNE MODULATOR
EP3919491C0 (en) AKT INHIBITOR
DK3946179T3 (da) Stomiposer
DK3840767T3 (da) Peptider
EP3967649C0 (en) LIPID NANOPARTICLE
EP3742771C0 (en) M2M SM-SR TO SM-DP NOTIFICATION
EP4072381A4 (en) Headboard
EP4034170A4 (en) TGF-BETA RELATED POLYPEPTIDES
EP3975220A4 (en) Display panel
EP3973348A4 (en) HEAD MOUNT DISPLAYS
EP3957391C0 (en) AGITATOR
EP3912517C0 (en) FRAME
EP4082837A4 (en) Roof box
EP3965638C0 (en) VAGINAL SPECULUM
EP3962498A4 (en) Combination therapies
DK3738452T3 (da) Fordamper
EP3682831C0 (en) CRYOGENIC APPLICATOR
EP3914606A4 (en) CYCLIC PEPTIDE
EP4063289C0 (en) CROWN CAPSULE
EP4011930A4 (en) PREPREG
PL3974027T3 (pl) Stabilizowany peptyd pacap